The compnay just wanted a decision... in or out. Getting this decision is the best thing.
APP have so much turnover at the top within the company that this is a blessing.
Getting another deal will no be a problem.. i think you are underestimating the risk cycle of the product:- generic, success in trials showing that in time it will dominate, chemical equivalence for approval only... patents dissappearing and other oncology discoveries in the pipeline.....
I am delighted with the outcome. ACL can now progress!
Anyway just my humble Biased opinion.
re:partnership officially broken, page-11
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable